| Status | Study |
| Not yet recruiting |
Study Name: A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) Condition: Anemia, Hemolytic, Autoimmune Date: 2017-03-03 Interventions: Drug: SYNT001 IV in 250 mL over 1 hour administered on Day 0, 7, 14, 21, and 28 |
| Recruiting |
Study Name: Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2016-06-23 Interventions: Biological: blood sample |
| Completed |
Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease Condition: Cold Agglutinin Disease Autoimmune Hemolytic Anemia Date: 2016-02-16 Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab |
| Recruiting |
Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) Condition: Warm Antibody Autoimmune Hemolytic Anemia Date: 2015-11-19 Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti |
| Recruiting |
Study Name: Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders Condition: Bullous Pemphigoid (BP) Cold Agglutinin Disease Warm Date: 2015-07-07 Interventions: Drug: TNT009 Other: Placebo |
| Recruiting |
Study Name: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment Condition: Autoimmune Hemolytic Anemia Date: 2015-02-13 Interventions: Drug: Interleukine-2 Four courses of IL2 ( [Proleukin, Nov |
| Recruiting |
Study Name: Immunopathology of Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2014-03-05 Interventions: Biological: blood samples |
| Active, not recruiting |
Study Name: Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease Condition: Refractory Cold Agglutinin Disease Date: 2012-09-27 Interventions: Drug: Bortezomib |
| Not yet recruiting |
Study Name: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. Condition: Anemia Anemia, Hemolytic Anemia, Hem Date: 2012-04-13 Interventions: Drug: levamisole |
| Completed |
Study Name: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type) Date: 2011-04-28 Interventions: Drug: prednisone, low dose rituximab Patients with "w |